Ebrotidine, a unique H-2-receptor antagonist, with gastroprotective activity against acid-dependent and acid-independent ulcerogens.

被引：0

作者：

Brzozowski, T

Konturek, SJ

Konturek, PC

Hahn, EG

机构：

[1] KRAKOW TECH UNIV, SCH MED, EG HAHN INST PHYSIOL, PL-31155 KRAKOW, POLAND

[2] UNIV ERLANGEN NURNBERG, DEPT MED, D-8520 ERLANGEN, GERMANY

来源：

GASTROENTEROLOGY | 1997年 / 112卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：A351 / A351

页数：1

共 48 条

[31] EFFECTS OF IT-066, A NEW HISTAMINE H-2-RECEPTOR ANTAGONIST, ON GASTRIC-ACID SECRETION AND EXPERIMENTAL GASTRIC-ULCERS IN RATS AND DOGS
OKABE, S
NISHIDA, T
IGATA, H
TAKAGI, K
FOLIA PHARMACOLOGICA JAPONICA, 1990, 95 (05) : 247 - 256
[32] INHIBITION OF GASTRIC-ACID SECRETION BY THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST AH 19065 (RANITIDINE) AND CIMETIDINE - DOUBLE-BLIND TRIAL
HAGENMULLER, F
ZEITLERABUISHIRA, A
CLASSEN, M
GUT, 1979, 20 (10) : A905 - A905
[33] EFFECT OF AN H+, K+-ATPASE INHIBITOR, OMEPRAZOLE (OPZ), ON GASTRIC-ACID SECRETION AND GASTRIC OR DUODENAL LESION - COMPARISON WITH AN H-2-RECEPTOR ANTAGONIST, FAMOTIDINE (FMD)
HAGA, K
ASANO, K
OSUGA, K
MARUYAMA, Y
FOLIA PHARMACOLOGICA JAPONICA, 1988, 92 (01) : 39 - 47
[34] THE EFFECTS OF 75 MG HOE 760, A NOVEL H-2-RECEPTOR ANTAGONIST, ON DAYTIME PEPTONE-STIMULATED AND NOCTURNAL GASTRIC-ACID OUTPUT IN HEALTHY-VOLUNTEERS
HAGENMULLER, F
WEBER, C
HAUSMANN, S
LABS, R
MALERCZYK, V
DELOOZE, S
CLASSEN, M
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 (05) : 609 - 614
[35] THE EFFECT OF WHR-2568, A NEW HISTAMINE H-2-RECEPTOR ANTAGONIST, ON NOCTURNAL AND PENTAGASTRIN-STIMULATED GASTRIC-ACID SECRETION IN DUODENAL-ULCER PATIENTS
KOSS, MA
WOLOSIN, JD
HOGAN, DL
ISENBERG, JI
GASTROENTEROLOGY, 1987, 92 (05) : 1480 - 1480
[36] COMPARISON OF THE EFFECT OF OMEPRAZOLE - A SUBSTITUTED BENZIMIDAZOLE AND RANITIDINE - A POTENT H-2-RECEPTOR ANTAGONIST - ON HISTAMINE-INDUCED GASTRIC-ACID SECRETION AND THE ULTRASTRUCTURE OF CANINE PARIETAL-CELLS
STACHURA, J
KONTUREK, SJ
CIESZKOWSKY, M
DABROS, W
ZAKRZEWSKA, J
KONTUREK, J
HEPATO-GASTROENTEROLOGY, 1983, 30 (05) : 205 - 210
[37] BASAL AND PEAK ACID OUTPUTS AND INTRA-GASTRIC ACIDITY ARE REDUCED FOR 24 HOURS BY A SINGLE DAILY DOSE OF THE HISTAMINE H-2-RECEPTOR ANTAGONIST SK+F93479
MILLS, JG
JONSSEN, KA
CLANCY, A
BODEMAR, G
VINCENT, D
NORLANDER, B
WALAN, A
HUNT, RH
BURLAND, WL
GUT, 1981, 22 (10) : A878 - A878
[38] REPEATED PENTAGASTRIN-STIMULATED GASTRIC-ACID SECRETORY TESTS CARRIED OUT IN THE EVALUATION OF THE PHARMACODYNAMICS OF A NEW HISTAMINE H-2-RECEPTOR ANTAGONIST, SK-AND-F-93479
JONSSON, KA
BODEMAR, G
NORLANDER, B
WALAN, A
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1984, 19 (02) : 209 - 215
[39] INHIBITION OF PENTAGASTRIN-STIMULATED GASTRIC-ACID SECRETION AND PLASMA-LEVELS OF THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST RAMIXOTIDINE DIHYDROCHLORIDE (CM-57755) IN HUMAN VOLUNTEERS
BRASSINNE, A
DRESSE, A
BASILISCO, G
MANARA, L
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (05) : 467 - 470
[40] RETINOIC ACID-DEPENDENT TRANSACTIVATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PROMOTERS BY THE NUCLEAR HORMONE RECEPTOR H-2RIIBP IN UNDIFFERENTIATED EMBRYONAL CARCINOMA-CELLS
NAGATA, T
SEGARS, JH
LEVI, BZ
OZATO, K
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (03) : 937 - 941

← 1 2 3 4 5 →